MedTrace Logo

Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

NCT07007390 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-06-05

No results posted yet for this study

Summary

The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.

Conditions

  • ALS
  • ALS (Amyotrophic Lateral Sclerosis)

Sponsors & Collaborators

  • Universidade Federal de Santa Catarina

    collaborator OTHER

  • Viome

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2030-02-01
Completion
2030-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07007390 on ClinicalTrials.gov